Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Anesthesia and Analgesia|October 27, 2004
The efficacy and safety of oral immediate-release oxymorphone for postsurgical painJoseph Gimbel, Harry Ahdieh
American Journal of Therapeutics|March 16, 2005
Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year studyHarris McIlwain, Harry Ahdieh
Pharmacotherapy|April 22, 2004
Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover studyMichael P Adams, Harry Ahdieh
Drugs in R&D|March 22, 2005
Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tabletsMichael P Adams, Harry Ahdieh
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot studyPaul Sloan, Neal Slatkin, Harry Ahdieh
Current Medical Research and Opinion|June 18, 2004
Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled studyNashat Y Gabrail, Chris Dvergsten, Harry Ahdieh
Pain Medicine (Malden, Mass.)|November 4, 2005
Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trialAlan K Matsumoto, Najib Babul, Harry Ahdieh
Pain Medicine (Malden, Mass.)|October 28, 2008
Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe painRichard Rauck, Tina Ma, Rosemary Kerwin, et al.
Journal of Clinical Pharmacology|June 17, 2004
Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplastyHarry Ahdieh, Tina Ma, Najib Babul, et al.
The Journal of Pain|December 6, 2006
Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled studyMartin E Hale, Harry Ahdieh, Tina Ma, et al.
Pageof 2